Press ReleasesThurs. 9/15/2011
"Contagion" Scenario: Nexera Medical On Leading Edge Of Airborne Microbe Protection With Its Next Generation Surgical Respirator Mask
Nexera Medical, Inc. Announces that it plans to submit new data to the U.S. Food and Drug Administration (FDA) to amend its current 510K medical device clearance to include certain strains of viruses.
Nexera Medical Receives Simultaneous FDA 510K and NIOSH Clearance of New SpectraShield™ Antibacterial N95 Respirator Mask Using Fosshield® Technology
As Flu Retreats, Scientists Brace for Its Return - The H1N1 Virus, Strains of Which Have Circulated for Decades, Could Come Back in a More Virulent Form
Swine Flu Outbreak Prompts Nexera Medical to Donate Antimicrobial Reusable N99 Respirator Masks to a Regional Office of The World Health Organization...
Nexera Medical, Inc. files with the U.S. Food and Drug Administration ("FDA") for the SpectraShield™ 9900 as an antimicrobial surgical mask...
Nexera Medical's SpectraShield™ Plus FFP3 receives EN 149 approval as a FFP3 (French Version) respirator mask from INSPEC International Ltd., a European Union certified testing facility...
Nexera Medical's SpectraShield ™ Plus FFP3 Antimicrobial Respirator Mask passes Virucidal Testing for antimicrobial efficacy at RetroScreen Virology Ltd., a European Union certified testing facility...
Nexera Medical receives formal evaluation results for Antimicrobial Activity for SpectraShield™ Plus FFP3 Antimicrobial Respirator Mask from Health Protection Agency...
Innovative Fosshield® Antimicrobial Technology Shown to Continuously Kill MRSA 'Superbug'
Nexera Medical Obtains a Medical Device Establishment License for SpectraShield™ 9900 Antibacterial Respirator Mask in Canada
For French Version Click Here
Foss Manufacturing's Fosshield® Protects NASA Crew's Clothing and Linens from Destructive and Odor-Causing Bacteria
Copyright © 2021 Nexera Medical. All rights reserved.